Showing results (191-200 of 213) with videos related to

Sort By:
Pageof 22
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 27, 2025
Recurrence rate, features, and outcome after hepatocellular carcinoma curative resection or ablation according to the IMbrave050 criteria: a real-world studyEdoardo G Giannini, Andrea Pasta, Laura Bucci, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 21, 2020
The changing scenario of hepatocellular carcinoma in Italy: an updateFrancesca Garuti, Andrea Neri, Francesca Avanzato, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 29, 2022
Potential feasibility of atezolizumab-bevacizumab therapy in patients with hepatocellular carcinoma treated with tyrosine-kinase inhibitorsBenedetta Stefanini, Laura Bucci, Valentina Santi, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 1, 2024
Characteristics and outcome of anti-hepatitis D virus positive patients with hepatocellular carcinomaEdoardo G Giannini, Andrea Pasta, Giulia Pieri, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 23, 2020
Comparison of prognostic models in advanced hepatocellular carcinoma patients undergoing Sorafenib: A multicenter studyGiovanni Marasco, Antonio Colecchia, Maria Letizia Bacchi Reggiani, et al.
Hepatology Communications|July 28, 2025
Outcome of hepatic resection for HCC in ideal and non-ideal candidatesLorenzo Lani, Laura Bucci, Valentina Santi, et al.
JHEP Reports : Innovation in Hepatology|July 31, 2023
Landscape of alcohol-related hepatocellular carcinoma in the last 15 years highlights the need to expand surveillance programsNicola Reggidori, Laura Bucci, Valentina Santi, et al.
Gut|December 22, 2021
Epidemiological trends and trajectories of MAFLD-associated hepatocellular carcinoma 2002-2033: the ITA.LI.CA databaseAlessandro Vitale, Gianluca Svegliati-Baroni, Alessio Ortolani, et al.
Journal of Hepatology|April 9, 2019
Direct-acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patientsGiuseppe Cabibbo, Ciro Celsa, Vincenza Calvaruso, et al.
Pageof 22